Autosomal Dominant Polycystic Kidney Clinical Trials

24 clinical trials for Autosomal Dominant Polycystic Kidney across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases — RECRUITING · NA
• A Prospective Observational Study of Foam Sclerotherapy . — RECRUITING
• Glucagon-Like Peptide-1 Receptor Agonist in ADPKD — RECRUITING · PHASE2
• Analysis of Patients With Autosomal Dominant Polycystic Kidney — RECRUITING
• A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease — RECRUITING · PHASE2
• Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD — ACTIVE_NOT_RECRUITING · NA
• Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD) — ACTIVE_NOT_RECRUITING · PHASE4
• Outcome of ADPKD With Octreotide LAR — ACTIVE_NOT_RECRUITING
• Treatment of Vascular Stiffness in ADPKD — COMPLETED · PHASE4
• Daily Caloric Restriction in ADPKD — ACTIVE_NOT_RECRUITING · NA
• Effect of Beetroot Juice on Reducing Hypertension in Autosomal Dominant Polycystic Kidney Disease — COMPLETED · NA
• A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX — COMPLETED · PHASE2
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) — TERMINATED · PHASE3
• A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — TERMINATED · PHASE3
• Statin Therapy in Patients With Early Stage ADPKD — ACTIVE_NOT_RECRUITING · PHASE4
• Thyroid Hormones in ADPKD — COMPLETED · NA
• Dietary Intervention in ADPKD on Tolvaptan — COMPLETED · NA
• A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease — COMPLETED · NA
• Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts — OTHER · NA
• Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD — COMPLETED · PHASE2
• Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease — TERMINATED · PHASE3
• To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers — COMPLETED · PHASE1
• Wishing to Decrease Aquaresis in ADPKD Patients Treated With a V2Ra; the Effect of Regulating Protein and Salt — OTHER · NA
• Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease — OTHER · PHASE4

Refine this search